R1 RCM - RCM Stock Forecast, Price & News

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft increased their price objective on R1 RCM from $26.00 to $31.00 in a research note on Thursday, August 4th. TheStreet raised R1 RCM from a "d" rating to a "c" rating in a report on Monday, May 9th. Barclays reaffirmed an "overweight" rating and issued a $29.00 target price on shares of R1 RCM in a report on Wednesday, June 29th. Finally, JPMorgan Chase & Co. started coverage on R1 RCM in a report on Monday, August 1st. They issued an "overweight" rating for the company. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $30.17.

R1 RCM Stock Performance

NASDAQ:RCM traded up $0.15 on Friday, hitting $25.78. 1,374,090 shares of the stock traded hands, compared to its average volume of 1,256,862. The business's fifty day moving average is $22.77 and its two-hundred day moving average is $23.86. R1 RCM has a 12 month low of $18.71 and a 12 month high of $27.86. The firm has a market capitalization of $10.73 billion, a price-to-earnings ratio of 143.23, a PEG ratio of 6.10 and a beta of 0.91. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.54 and a current ratio of 1.57.

Insider Buying and Selling at R1 RCM

In other news, insider John M. Sparby sold 4,365 shares of the firm's stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $26.03, for a total value of $113,620.95. Following the completion of the transaction, the insider now directly owns 163,772 shares of the company's stock, valued at $4,262,985.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider John M. Sparby sold 4,365 shares of the firm's stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $26.03, for a total value of $113,620.95. Following the completion of the transaction, the insider now directly owns 163,772 shares of the company's stock, valued at $4,262,985.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John M. Sparby sold 4,691 shares of the firm's stock in a transaction on Tuesday, August 9th. The stock was sold at an average price of $25.83, for a total value of $121,168.53. Following the completion of the transaction, the insider now directly owns 188,137 shares of the company's stock, valued at $4,859,578.71. The disclosure for this sale can be found here. 59.40% of the stock is owned by corporate insiders.